版本:
中国

BRIEF-Cytodyn's Pro 140 for treating HIV deemed too broad for orphan drug designation by FDA

April 17 Cytodyn Inc

* Potential for Cytodyn's PRO 140 for treating HIV patients deemed too broad for orphan drug designation by the FDA

* Cytodyn Inc - application for orphan drug designation not granted by office of orphan products development of U.S. Food and Drug Administration (FDA) Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐